Judge OKs $264M Deal Ending Mylan EpiPen Price-Hike Suit
By Jonathan Capriel · March 14, 2022, 9:01 PM EDT
A Kansas federal court has preliminarily approved a $264 million deal that would end claims that Mylan colluded with Pfizer Inc. to obstruct generic versions of the EpiPen, the emergency drug...
To view the full article, register now.